The expression of COL6A3 in V727M mutation–harboring GNE patients was higher than 2.5-fold in comparison to all myositis (Polymyositis, Inclusion-Body Myositis, Dermatomyositis, and Non-specific myositis). Here, COL6A3 is linked to inclusion body myositis.